82 FR 41630 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 82, Issue 169 (September 1, 2017)

[Federal Register Volume 82, Number 169 (Friday, September 1, 2017)]
[Notices]
[Pages 41630-41631]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-18613]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant proposals applications and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant proposals 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Clinical and Translational R21 and Omnibus R03: SEP-6.
    Date: October 13, 2017.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Jennifer C. Schiltz, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W112, Bethesda, MD 20892-9750, 240-276-5864, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Institutional Research Training Grant.
    Date: October 17, 2017.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W234, Rockville, MD 20850 (Telephone Conferece 
Call).
    Contact Person: Adriana Stoica, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W234, Bethesda, MD 20892-9750, 240-276-6368, 
[email protected].

    Name of Committee: National Cancer Institute Initial Review 
Group; Subcommittee I--Transition to Independence.
    Date: October 18-19, 2017.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Crystal City, 2799 Jefferson Davis Highway, 
Arlington, VA 22202.
    Contact Person: Delia Tang, M.D., Scientific Review Officer, 
Research Programs Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W602, Bethesda, MD 20892-9750, 240-276-6456, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP 2 for Provocative Questions.
    Date: October 24, 2017.
    Time: 8:00 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Ombretta Salvucci, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W264, Bethesda, MD 20892-9750, 240-276-7286, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Clinical and Translational R21 and Omnibus R03: SEP-5.
    Date: November 15-16, 2017.
    Time: 6:00 p.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 41631]]

    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Jun Fang, Ph.D., Scientific Review Officer, 
Research Technology & Contract Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W246, Bethesda, MD 20892-9750, 240-276-5460, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Clinical and Translational R21 and Omnibus R03: SEP-2.
    Date: November 16-17, 2017.
    Time: 6:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Yasuko Furumoto, Ph.D., Scientific Review 
Officer, Research Technology & Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W634, Bethesda, MD 20892-9750, 240-276-5287, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: August 29, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-18613 Filed 8-31-17; 8:45 am]
 BILLING CODE 4140-01-P